SCEJ

$B2=3X9)3X2q(B $BBh(B85$BG/2q(B

$B9V1i?=$79~$_0lMw!J%7%s%]%8%&%`!&9V1iJ,N`JL!K(B

7) $B%P%$%*(B

7-e. $B%a%G%#%+%k(B

$B:G=*99?7F|;~!'(B2020-09-26 15:59:01

$B$3$NJ,N`$G$h$/;H$o$l(B
$B$F$$$k%-!<%o!<%I(B		$B%-!<%o!<%I(B$B
molecularly imprinted polymer3$B7o(B*
tissue engineering3$B7o(B*
hydrogel3$B7o(B*
sensor2$B7o(B
nanoparticles2$B7o(B
Spheroid2$B7o(B
bioprinting2$B7o(B
biomaterial2$B7o(B
antitumor effect2$B7o(B
Drug Delivery1$B7o(B

$B$BHV9f(B$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BH/I=7A<0(B
75$BB.EYO@%b%G%k$rMQ$$$?3QKl>eHi:YK&%7!<%H$N5sF02r@O(B
($B:eBg1!9)(B) ($B3X(B)$B!{>e2,(B $BFWLi(B$B!&(B ($B:eBg(B) $B:4!9LZ(B $B7<(B$B!&(B ($B:eBg1!9)(B) Nguyen Thi Nhu Trang$B!&(B ($B:eBg1!0e(B) $BGO>l(B $B9L0l(B$B!&(B($B%8%c%Q%s!&%F%#%C%7%e!&%(%s%8%K%"%j%s%0(B) $BEDCf(B $BJ~Be!&(B $B;{@>(B $BM[M'(B$B!&(B $B>.3^86(B $BN49-(B$B!&(B $B0f2H(B $B1WOB(B$B!&(B $BH+(B $B8-0lO:(B$B!&(B ($B:eBg1!0e(B) $B@>ED(B $B9,Fs(B$B!&(B ($B:eBg1!9)(B) ($B@5(B)$B5*%N2,(B $B@5Gn(B		Computer simulation
Cellular behavior
Kinetic model
P
139$B5!G=@-%^%F%j%"%kI>2A$K$*$1$k:YK&7ABV2hA|2r@O$rMQ$$$?:YK&e(B
($BL>BgAOLt(B) ($B3X(B)$B!{@>(B $BNC9a(B$B!&(B ($B@5(B)$B3*9>(B $B7E(B$B!&(B $B:#0f(B $BM4B@(B$B!&(B ($B3X(B)$BC]K\(B $BM*?M(B$B!&(B ($BL>BgAOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`(B) ($B@5(B)$B2CF#(B $BN5;J(B		cell quality
biomaterial
peptide
P
160$B%H%l%O%m!<%9$r4pHW$H$7$?:YK&E`7kJ]8n:^$N3+H/(B
($B6eBg1!2=9)(B) $BD3Ln(B $BM:Bg(B$B!&(B $B5HED(B $B>?(B$B!&(B ($B6eBg(BGIC) ($B@5(B)$B>.Ln(B $BJ8Lw(B$B!&(B ($B6eBg1!2=9)(B) ($B@5(B)$BGrLZ@n(B $BF`:Z(B$B!&(B ($B@5(B)$B:f(B $BM5Je(B$B!&(B ($B@5(B)$B!{0fEh(B $BGnG7(B		cryoprotectant
trehalose
hepatocytes
O
247$B%R%"%k%m%s;@FC0[E*7k9gG=$r;}$D5!G=2=%j%s%/%b%8%e!<%k$N3+H/(B
($BElBg1!9)(B) ($B3X(B)$B!{Bg@n(B $B>-;V(B$B!&(B $BEDIt(B $B0!5((B$B!&(B ($BElBg1!0e(B) ($B@5(B)$BB@ED(B $B@?0l(B$B!&(B ($BElBg0e2J8&(B) ($B@5(B)$BD9Lg@P(B $BZ|(B$B!&(B ($BElBg1!9)(B/$BElBg0e2J8&(B) $BDEK\(B $B9@J?(B$B!&(B ($BElBg1!9)(B/$BElBg1!0e(B) ($B@5(B)$B0KF#(B $BBgCN(B		hyaluronan binding protein
transglutaminase
link module
P
263$BMM!9$JAH@.$N%2%k4pHD>e$K$*$1$k:YK&M7Av;n83$N$?$a$N(Binkjet$B<0%W%j%s%F%#%s%0$K$h$k:YK&%Q%?!<%K%s%0(B
($B:eBg1!4p9)(B) ($B3X(B)$B!{LZB<(B $BH~L4(B$B!&(B Enkhtuul Gantumur$B!&(B Mubarok Wildan$B!&(B ($B@5(B)$B6-(B $B?5;J(B		hydrogel
inkjet printing
cell patterning
P
338$B%H%l%O%m!<%9%j%]%=!<%`$NF}$,$s$KBP$9$k%"%]%H!<%7%9M6F3$K$h$k<#NE8z2L(B
($B?r>kBg1!1~MQ@8L?(B) ($B3X(B)$B!{1`ED(B $B??M3h=(B$B!&(B ($B@5(B)$B7,86(B $B7<;J(B$B!&(B ($B@5(B)$B;T86(B $B1QL@(B$B!&(B ($B@5(B)$B>>K\(B $BM[;R(B		antitumor effect
trehalose liposome
breast cancer
P
341$BC@4I$,$s$KBP$9$k%+%A%*%s%j%]%=!<%`$N<#NE8z2L(B
($B?r>kBg1!1~MQ@8L?(B) ($B3X(B)$B!{|bLZ(B $BGn=<(B$B!&(B ($B@5(B)$B85B<(B $B=!@?(B$B!&(B ($B@5(B)$B;T86(B $B1QL@(B$B!&(B ($B@5(B)$B>>K\(B $BM[;R(B		antitumor effect
cationic liposome
cholangiocarcinoma
P
385$B2hA|2r@O$rMQ$$$?$,$s:YK&%9%U%'%m%$%I$K$*$1$kLt:^1~EzI>2A(B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{2CED(B $B$f$j;R(B$B!&(B $B=BED(B $B??7k(B$B!&(B $B2CF#(B $B42?M(B$B!&(B ($BC^GHBg0e(B) $BF|2$B!&(B ($BL>Bg1!AOLt(B) ($B@5(B)$B3*9>(B $B7E(B$B!&(B ($B9q$,$s8&%;(B) $BIpF#(B $BNQ90(B$B!&(B ($BC^GHBg0e(B) $B>>0f(B $BM5;K(B$B!&(B ($B;:Am8&AOLt4pHW(B) ($B@5(B)$B6b?9(B $BIR9,(B$B!&(B ($B%(%s%8%K%"%j%s%0%7%9%F%`(B) $BLxBt(B $B??@!(B$B!&(B ($B;:Am8&AOLt4pHW(B) $B?y1:(B $B?5<#(B$B!&(B ($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U(B) ($B@5(B)$B2CF#(B $BN5;J(B		cancer
image analysis
spheroid
P
410$BKl7?_I2a4o$H%2%kJqKd5[Ce:^$rAH$_9g$o$;$?7HBS7?7l1U>t2=%7%9%F%`$NDs0F(B
($BK!@/Bg1!M}9)(B) ($B3X(B)$B!{E"(B $B@.=a(B$B!&(B $B0f8MED(B $BD>OB(B$B!&(B ($B@5(B)$B;32<(B $BL@BY(B		blood purification
adsorbent
gel
P
412$B%I%i%C%0%G%j%P%j!<%7%9%F%`MQ%]%jF};@(B-$B%]%j%S%K%k%T%m%j%I%sJ?Kl$N3H;6F)2a@-$NI>2A(B
($BK!@/Bg1!M}9)(B) ($B3X(B)$B!{;0DM(B $B9'G=(B$B!&(B $B0f8MED(B $BD>OB(B$B!&(B ($B@5(B)$B;32<(B $BL@BY(B		Drug delivery system
Controlled release
Diffusion coefficient
P
429$B%"%k%D%O%$%^!
($BElBg1!0e(B) ($B@5(B)$B!{B@ED(B $B@?0l(B$B!&(B ($BElBg1!9)(B) $B>.LnB<(B $BCNG7(B$B!&(B ($BElBg1!0e(B/$BElBg1!9)(B) ($B@5(B)$B0KF#(B $BBgCN(B		Drug Delivery
Nanoparticles
Amyloid
O
430$B8w2M66@-%<%i%A%s$rMQ$$$?B?9&@-%O%$%I%m%2%k$NHy:Y2C9)$H:YK&G]M\(B
($B@iMUBg1!M;(B) $BL,ED(B $B5A>-(B$B!&(B ($B3X(B)$B!{KY(B $BM-2;(B$B!&(B ($B@iMUBg1!9)(B) $B1-F,(B $BM}7C(B$B!&(B ($B@5(B)$B;3ED(B $B??@!(B$B!&(B ($B@5(B)$B4X(B $B		tissue engineering
cell culture
hydrogel
P
453$B%7%k%/%U%#%V%m%$%s%J%N%U%!%$%P!<4^M-%$%s%/$rMQ$$$?(B3D$B%P%$%*%W%j%s%F%#%s%0(B
($B:eBg1!4p9)(B) ($B3X(B)$B!{5H0f(B $B:LG5(B$B!&(B ($B$J$,$9$JKz(B) $B1J:=(B $B=$(B$B!&(B $B]/0f(B $B=SJe(B$B!&(B ($B:eBg1!4p9)(B) ($B@5(B)$B6-(B $B?5;J(B		3D bioprinting/biofabrication
Biocompatibility
Fibre-based biomaterials
P
470$B%7%k%/%U%#%V%m%$%s%$%s%/$rMQ$$$?(B3D$B%P%$%*%W%j%s%F%#%s%05;=Q$N3+H/(B
($B:eBg4p9)(B) ($B3X(B)$B!{?9ED(B $B?rM5(B$B!&(B ($B:eBg1!4p9)(B) ($B3X(B)$B5H0f(B $B:LG5(B$B!&(B ($B@5(B)$B6-(B $B?5;J(B		silk fibroin
tissue engineering
bioprinting
P
472Direct implantation of $B&B(B cell aggregates using a hydrogel microwell device
(U. Tokyo) ($B3X(B)$B!{(BTulakarnwong Sarun$B!&(B (NCGM) Inagaki F Natsuko$B!&(B (U. Tokyo) ($B3X(B)Oki Yuichiro$B!&(B ($B@5(B)Ohta Seiichi$B!&(B Shinohara Marie$B!&(B ($B@5(B)Sakai Yasuyuki$B!&(B ($B@5(B)Ito Taichi		Hydrogel microwell
Spheroid
Insulinoma
P
510$BC1AXFsN22=%b%j%V%G%s$rMQ$$$?GK9|:YK&$N%W%m%H%sJ|=P7WB,(B
($BEl9)BgJ*$B!&(B $B$B!&(B $BLn8}(B $B9ID9(B$B!&(B ($B@5(B)$BEDCf(B $BM47=(B$B!&(B $BAa?e(B $BM5J?(B$B!&(B ($B@5(B)$BBg2OFb(B $BH~F`(B		2D nanosheet
Molybdenum disulfide
Osteoclast
P
522$B@8BNFb$G$N0dEA;RF3F~$r2DG=$H$9$k(Bplasmid$BC4;}%J%N%U%!%$%P!<$N3+H/(B
($B:eBg1!4p9)(B) ($B3X(B)$B!{8ELn(B $B6W;R(B$B!&(B $BNkLZ(B $B7<0lO:(B$B!&(B ($B@5(B)$B6-(B $B?5;J(B		electrospinning
gene delivery
in vivo
P
553Solid-in-Oil$B2=5;=Q$rMxMQ$7$?7PHi%G%j%P%j!<$K$h$k2VJ4>I<#NE8z2L(B
($B6eBg1!9)(B) ($B3X(B)$B!{ElEg(B $B90$B!&(B ($B3X(B)Kong Qingliang$B!&(B ($B@5(B)$BED86(B $B5AO/(B$B!&(B ($B@5(B)$B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B		Immunotherapy
Transdermal drug delivery system
T cell epitope peptide
P
5582$B$D$N9ZAGH?1~$rAH$_9g$o$;$?(B3D$B%P%$%*%W%j%s%F%#%s%05;=Q$N3+H/(B
($B:eBg4p9)(B) ($B3X(B)$B!{86ED(B $BNCJ?(B$B!&(B ($B:eBg1!4p9)(B) ($B3X(B)$B;3K\(B $BfFB@(B$B!&(B (Clermont Auvergne U.) Delattre Cédric$B!&(B ($B:eBg1!4p9)(B) ($B@5(B)$B6-(B $B?5;J(B		hydrogel
bioprinting
tissue engineering
P
570$B%-%H%5%s(B&$B%-%H%5%s%J%N%U%!%$%P!<4^M-%$%s%/$rMQ$$$?AO=}HoJ$:`$N(B3D$B%W%j%s%F%#%s%0(B
($B:eBg1!4p9)(B) ($B3X(B)$B!{;3K\(B $BfFB@(B$B!&(B ($B@5(B)$B6-(B $B?5;J(B		chitosan nanofibers
wound dressing
3D print
P
585$BCJ3,E*Cj=P$K$h$kA*Br@-$N9b$$%;%m%H%K%s8!=P7V8w@-J,;R%$%s%W%j%s%H%]%j%^!<%J%NN3;R$ND4@0(B
($B$B!&(B ($B@5(B)$B5H8+(B $BLwCK(B		serotonin
molecularly imprinted polymer
nanoparticles
P
596$B%"%_%m%$%I<1JL$rL\;X$7$?%"%_%m%$%I@-%?%s%Q%/
($B2,;3Bg1!4D@8(B) ($B3X(B)$B!{@>Hx(B $B3$?M(B$B!&(B ($B@5(B)$BEgFb(B $B$B!&(B ($B@5(B)$BLZB<(B $B9,7I(B		liposome
protein display
amyloids
P
602Recombinant antibody production using a transactivator system in CHO cells.
(Kyushu U.) ($B3X(B)$B!{(BGuo Ning$B!&(B ($B@5(B)Kawabe Yoshinori$B!&(B ($B3X(B)Zheng Feiyang$B!&(B ($B@5(B)Kamihira Masamichi		CHO cells
recombinant antibody
biopharmaceuticals
P
637$BJ,;R%$%s%W%j%s%H9bJ,;R8GDj%+!<%\%s%Z!<%9%HEE6K$rMQ$$$??75,7P8}936E8GLt%;%s%5$N3+H/(B
($B$B!&(B ($B@5(B)$B5H8+(B $BLwCK(B		edoxaban
molecularly imprinted polymer
sensor
P
642$BJ,;R%$%s%W%j%s%H9bJ,;R8GDj%0%i%U%!%$%H%Z!<%9%HEE6K$rMQ$$$?%a%m%Z%M%`%;%s%5$N:GE,2M66@-%b%N%^!
($B$B!&(B ($B@5(B)$B5H8+(B $BLwCK(B		meropenem
molecularly imprinted polymer
sensor
P
699$BCf6u;eFb;0u8z2L(B
($B6eBg1!9)(B) ($B@5(B)$B!{?eK\(B $BGn(B$B!&(B $BBg2l(B $BH~HA(B$B!&(B $B>>2<(B $B:;4u;R(B$B!&(B ($B3X(B)$BC+8}(B $BNJ(B$B!&(B ($B3X(B)$BLn85(B $B=m@8(B$B!&(B ($B@5(B)$B3a86(B $BL->0(B		iPS cells
differentiation
three-dimensional culture
O
730$B9386%Z%W%A%I$N7PHi?;F)B%?J5!G=$rM-$9$k%-%e!<%S%C%/1U>=@=:^$N3+H/(B
($B6eBg1!9)(B) ($B3X(B)$B!{>.:d(B $B=(EM(B$B!&(B ($B@5(B)$B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B		liquid crystal
transcutaneous drug delivery
peptide antigen
O
749$B%$%*%s1UBN$rMxMQ$7$?7PHi%Z%W%A%I%G%j%P%j!<$K$*$1$k%"%_%N;@%+%A%*%s$N1F6A(B
($B6eBg1!9)(B) ($B3X(B)$B!{F#_7(B $BM55.(B$B!&(B ($B@5(B)$BED86(B $B5AO/(B$B!&(B ($B@5(B)$B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B		ionic liquid
transdermal delivery
biomaterial
P
792S/O$B@=:^$rMQ$$$?7PHi%o%/%A%s$N:GE,EjM?@_7W(B
($B6eBg1!9)(B) ($B@5(B)$B8eF#(B $B2m9((B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B$B!&(B ($B@5(B)$B$B!&(B $BKL2,(B $BEm;R(B$B!&(B ($B3X(B)$B!{NS(B $BN?B@O:(B		vaccine
optimisation
Formulation
P
$B9V1i?=$79~$_0lMw(B($B%7%s%]%8%&%`HV9f!&9V1iJ,N`HV9fJL(B)
$B
$B2=3X9)3X2q(B $BBh(B85$BG/2q(B
(C) 2020 $B8x1W
Most recent update: 2020-09-26 15:59:01
For more information contact $B2=3X9)3X2q(B $BBh(B85$BG/2q(B $B
E-mail: inquiry-85awww3.scej.org
This page was generated by easp 2.46; update.pl 2.37 (C)1999-2015 kawase